MRK vs SOLV
By Alex · Tickerpine
Merck & Co., Inc. vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | SOLV |
|---|---|---|
| Price | $128.66 | $79.53 |
| Market cap | $317.77B | $13.77B |
| P/E ratio | 36.2 | 9.7 |
| ROE | 18.94% | 34.79% |
| Profit margin | 13.59% | 17.33% |
| Revenue growth | 4.90% | -3.00% |
| Dividend yield | 2.64% | — |
| Beta | 0.22 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs SOLV in plain English
- MRK is the bigger company — about 23.1× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 9.7 vs 36.2).
- SOLV earns a higher return on equity (35% vs 19%).
- MRK is growing revenue faster (5% vs -3%).
- MRK pays a dividend (2.64%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.